Korolenko T A, Svechnikova I G
Vestn Ross Akad Med Nauk. 1998(10):26-9.
The lysosomal pathway of intracellular protein degradation involves the cooperative action of proteinases, among which cysteine proteinases cathepsin B and cathepsin L are particularly important. The hypothesis that the abnormal ratio of proteinases/proteinase inhibitors (i.e. higher activities of proteinases and lower activities of their inhibitors) results in uncontrolled proteolysis and cellular dysfunctions has been experimentally tested. Cathepsin B was used as a marker of macrophagal lysosomes and cathepsin L was employed as a marker of hepatocytic lysosomes. Zymosan stimulation of macrophages was shown to induce increased secretion of macrophagal lysosomal enzymes into blood during early zymosan administration, followed by higher rates of phagocytosis and labilization of lysosomes both of macrophages and hepatocytes labilization. Macrophagal depression induced by gadolinium chloride in rats was also accompanied by increased secretion of acid hydrolases into blood and labilization of macrophageal lysosomes, which reflects the lysosomotropic properties of the agent. Gadolinium chloride prevented zymosan stimulation of macrophages in the liver, but not in the spleen and lung. A new approach is proposed to evaluate the functional activity of hepatocytic lysosomes by the marker lysosomal enzymes of macrophages (cathepsin B) and hepatocytes (cathepsin L). Possible modes of regulation of endogenous proteinases are considered with special emphasis on the protective function of endogenous proteinase inhibitors secreted by macrophages simultaneously with cathepsin B and other cysteine proteinases.
细胞内蛋白质降解的溶酶体途径涉及蛋白酶的协同作用,其中半胱氨酸蛋白酶组织蛋白酶B和组织蛋白酶L尤为重要。蛋白酶/蛋白酶抑制剂的异常比例(即蛋白酶活性较高而其抑制剂活性较低)会导致蛋白水解失控和细胞功能障碍这一假说已通过实验进行了验证。组织蛋白酶B被用作巨噬细胞溶酶体的标志物,组织蛋白酶L被用作肝细胞溶酶体的标志物。实验表明,在早期给予酵母聚糖刺激巨噬细胞时,会导致巨噬细胞溶酶体酶向血液中的分泌增加,随后巨噬细胞和肝细胞的吞噬作用增强以及溶酶体不稳定。氯化钆诱导的大鼠巨噬细胞抑制也伴随着酸性水解酶向血液中的分泌增加以及巨噬细胞溶酶体的不稳定,这反映了该药物的溶酶体亲和特性。氯化钆可阻止酵母聚糖对肝脏中巨噬细胞的刺激,但对脾脏和肺中的巨噬细胞无此作用。提出了一种通过巨噬细胞(组织蛋白酶B)和肝细胞(组织蛋白酶L)的标志物溶酶体酶来评估肝细胞溶酶体功能活性的新方法。文中考虑了内源性蛋白酶可能的调节方式,特别强调了巨噬细胞与组织蛋白酶B和其他半胱氨酸蛋白酶同时分泌的内源性蛋白酶抑制剂的保护功能。